Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • A study comparing 4D-150 and aflibercept for adults with abnormal blood vessel growth in the eye due to age-related macular degeneration

    Recruiting

    3 1 1 1
    Bulgaria France Germany Hungary Italy Latvia +3
  • Study of two initial doses of aflibercept for patients with newly diagnosed neovascular age-related macular degeneration

    Recruiting

    3 1 1 1
    Investigated drugs:
    Austria
  • Study of Surabgene Lomparvovec Compared to Ranibizumab for Adults with Wet Age-Related Macular Degeneration

    Recruiting

    3 1 1 1
    Investigated drugs:
    Austria Belgium Bulgaria Croatia Czechia France +7
  • Study of Port Delivery System with ranibizumab given every 36 weeks in patients with neovascular age-related macular degeneration

    Recruiting

    3 1 1 1
    Investigated drugs:
    Austria Czechia Denmark France Germany Greece +3
  • Study of Faricimab Treatment Given Every 24 Weeks in Patients with Age-Related Macular Degeneration

    Recruiting

    3 1 1 1
    Investigated drugs:
    France Germany Italy Spain
  • Study on Long-Term Safety of Ranibizumab for Patients with Wet Age-Related Macular Degeneration Using a Port Delivery System

    Recruiting

    3 1 1 1
    Investigated drugs:
    Austria Belgium France Germany Italy Spain
  • Study on Vitrectomy, Alteplase, and Aflibercept for Patients with Wet Age-Related Macular Degeneration and Submacular Hemorrhage

    Recruiting

    3 1 1 1
    Investigated drugs:
    Germany Ireland The Netherlands Poland Spain
  • Long-term Safety and Effectiveness Evaluation of RGX-314 in Patients with Neovascular Age-related Macular Degeneration

    Not yet recruiting

    2 1 1
    France Germany Hungary Italy Spain
  • Study on the Use of SB11 Pre-Filled Syringe for Patients with Wet Age-Related Macular Degeneration, Macular Edema from Retinal Vein Occlusion, or Myopic Choroidal Neovascularization

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Poland
  • Study Comparing EYP-1901 and Aflibercept for Patients with Wet Age-Related Macular Degeneration

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Czechia Germany Hungary Poland Slovakia